ReviewFrontiers in neurology2026

Exendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury.

Shan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.